Novartis CEO: Straight talk on industry woes

07drug-75
Daniel L. Vasella, chief executive of Novartis, the $39 billion pharmaceutical giant based in Switzerland, says that even though Americans have made progress in curing some diseases, they face a major increase in obesity- and aging-related diseases. More importanly, in an interview with the NY Times, he talks about drug prices and the pharmaceutical industry. This is a message that needs to be hear by those in Congress and Amercian consumers. Read More...
|